NEW! Funding Opportunity for the Early Independence Award (EIA) Initiative: http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-14-004.html.
Letters of Intent are due on December 30, 2014. The application due date is January 30, 2015. Learn more about the EIA program here!
NEW! The NIH Common Fund Glycoscience Program is focused on creating new methodologies and resources to study glycans and to develop these resources so they may be more easily understood and accessed by the broader biomedical research community. To this effort, the Glycoscience Program has recently released four new Funding Opportunity Announcements (FOAs).
The Glycoscience Program will host a technical assistance workshop for potential applicants to the recently released FOAs on October 20, 2014.
To read about the new Glycoscience FOAs and learn more about the workshop, visit the Glycoscience website here.
NEW! Funding Opportunity Announcement: Model Organisms Screening Center for the Undiagnosed Diseases Network (UDN) (U54)
Funding Opportunity Announcement (FOA) to establish a Model Organisms Screening Center for evaluating the pathogenicity and function of approximately 200 gene variants per year identified through the Undiagnosed Disease Network (UDN). Responsive applications will propose to establish a screening platform involving at a minimum, Drosophila and zebrafish models. The screening pipeline may include additional small animal models or cell-based assays, as appropriate. For more information about this latest FOA from the UDN, visit here.
NEW! 4D Nucleome Program Issues Six Funding Opportunity Announcements!
The Common Fund 4D Nucleome program aims to understand the principles underlying nuclear organization in space and time, the role nuclear organization plays in gene expression and cellular function, and how changes in nuclear organization affect normal development as well as various diseases. To read about the new 4D Nucleome Funding Opportunity Announcements, visit the 4D Nucleome website here.
NEW! When Sex Matters: Announcing supplemental awards that address sex differences in NIH-funded research.
New funding, which includes 18 Common Fund supplements, will explore the effects of sex in both preclinical and clinical studies.